|

Lemborexant 10 mg Clinical Trials

1 actively recruiting trial across 1 location

Also known as: DAYVIGO

Pipeline

Phase 2: 1

Top Sponsors

  • Washington University School of Medicine1

Indications

  • Alzheimer's Disease1
  • Alzheimer Disease1

St Louis, Missouri1 trial

DORA and LP in Alzheimer's Disease Biomarkers

Washington University in St. Louis, School of Medicine

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.